HIV Clinical Trials
Recruiting hiv studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat hiv. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting hiv studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting hiv trials
Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations
Healthy Choices to Reduce Stigma and Improve Self-Management of Alcohol and HIV Among Young Adults
Intervention to Reduce Implicit Bias in Pharmacies
Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida
PrEPwise Pilot Among Black Women in Eastern Virginia
Project SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk Behavior
Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya
HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs) in Nigeria
Integrated Health Services (IHS): A Structural Intervention to Improve HIV/STI Screening and PrEP Navigation in Primary Care
Yuva Sath: A Peer-led Behavioral Intervention to Support Substance Use Treatment and HIV Prevention Among Young People Who Inject Drugs in India
A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs
Leveraging Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy (PHARM ART) in Community Clinics
Decision Support Tool to Integrate PrEP Into Emergency Departments
Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers
Improving HIV Prevention and Substance Use Post-Sexual Assault Services
Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program
Optimizing Implementation of Long Acting Injectable PrEP
Implementation of PrEP Care Among Women in Family Planning Clinics
A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV
Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach
Theoretically Informed Behavioral Intervention
Peer-led Community-based PrEP Delivery Among Youth in Brazil
People & Place: Impacts on Substance Use and HIV Outcomes in Los Angeles
Baricitinib Curative Repression of HIV-1
DYnamic decisioN Support for IntegrAting PrEP in Clinics for Young People in Alabama and Botswana
Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)
Adaptation and Evaluation of an Intersectional Stigma Reduction Intervention to Increase HIV Care Engagement Among Women Who Use Drugs
PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men
Digital Intervention Delivered Via Street Medicine to Increase HIV and Substance Use Care Among Survivors of Sex Trafficking
TelePharm PrEP/PEP
INTEGRATE-RX: Integrating Clinical Pharmacists in HIV Care to Mitigate Last-Mile Challenges and Reduce Cardiovascular Disease Burden
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
Developing an HIV Disclosure Intervention for Men in Uganda
Confidential Care and Adolescent HIV Testing
Development of a Multilevel HIV Prevention Intervention for the Emergency Department
Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.
HIV Testing in Community Health Center Dental Clinics
Harmonized Healing: Personalized Music Interventions to Address Chronic Pain in People Living With HIV
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)
Pharmacy-based Provision of Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in Tanzania
Genistein for the Reduction of Adverse Cardiovascular Events (GRACE)
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
Addressing Barriers to Anti-hypertensive Medication Adherence Among PLWH Who Have Achieved Viral Suppression
Reducing Stigma and Building Employability Skills for Young People With HIV in Zambia
NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings
Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People With HIV: a Randomized Clinical Trial
Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults
Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF
RISE: Reducing Cancer and HIV Stigma Through Empowerment
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
Evaluating the Healthy Families PrEP Program for Women at Risk for HIV
Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Alabama
Smoking Cessation Program for Lao People With HIV
Integrating U=U Into HIV Counseling in South Africa (INTUIT-2.0)
New trials in San Francisco, CA?
Pick a condition and we'll email you once a week when a new study starts recruiting in San Francisco, CA. Unsubscribe anytime.
HIV clinical trials — common questions
Are hiv clinical trials free to join?
Yes. Participating in a hiv clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a hiv clinical trial?
Each hiv study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a hiv trial near me?
Use the location controls above. We'll show recruiting hiv trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many hiv trials are recruiting right now?
We're currently tracking roughly 244 recruiting hiv trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.